Pristiq is an antidepressant medication used to treat major depressive disorder (MDD) in adults. It belongs to a class of medications called serotonin-norepinephrine reuptake inhibitors (SNRIs). It works by increasing the levels of serotonin and norepinephrine, two chemical messengers in the brain that help regulate mood.
Pristiq was approved by the U.S. Food and Drug Administration (FDA) in 2008. It is manufactured by Pfizer, Inc., and is available as 50, 100 and 150 mg tablets. Pristiq is also available in a generic form, desvenlafaxine.
The active ingredient in Pristiq is desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor (SNRI). It works by increasing the levels of serotonin and norepinephrine, two chemical messengers in the brain that help regulate mood. Desvenlafaxine is also available in other brand names, including Khedezla, Desfax, and Pexeva.
Advantages of Pristiq include its effectiveness in treating major depressive disorder, its low potential for abuse, and its low risk of side effects. It is also generally well-tolerated and can be taken with or without food.
Pristiq is not recommended for use in children due to a lack of safety and efficacy data in this age group. It is also not recommended for use in pregnant or breastfeeding women due to the potential for harm to the fetus or infant.
In conclusion, Pristiq is an effective and generally well-tolerated antidepressant medication used to treat major depressive disorder in adults. Its active ingredient, desvenlafaxine, is also available in other brand names. It is important to note that Pristiq is not recommended for use in children, pregnant or breastfeeding women.